Phase Transitions in Cellular Signaling and Disease
About This Grant
PROJECT SUMMARY Funds are requested to provide partial support for the inaugural FASEB Science Research Conference (SRC) on biomolecular condensates, titled "Phase Transitions in Cellular Signaling and Disease”, to be held from January 11–15, 2026, in Melbourne, Florida, USA. Biomolecular condensation has been recently discovered to be a ubiquitous phenomenon in living systems, supporting normal physiology and driving disease processes, including cancers and neurological disorders. These discoveries have generated immense interest among biologists, chemists, physicists, engineers, and computer scientists to develop an integrated experimental, theoretical, and computational framework to understand phase transition as a mechanism for programming cellular signaling, stress regulation, and genome organization. Aberrant behaviors of condensates have been shown to result in alterations in soluble protein homeostasis, dysregulation of signaling events in the cytoplasm, and activation of oncogenic transcriptional programs in the nucleus. These discoveries have also fueled new directions in drug discovery research, which are currently pursued by biotech and pharma companies. The 2026 conference on biomolecular condensates will feature two keynote lectures, 30 invited speakers and session chairs, including rising stars, and up to 150 attendees. The specific objectives of the conference are to stimulate and enable: 1) scientific knowledge exchange, both among academic researchers and between academia and industry, 2) professional networking and collaboration, and 3) peer mentoring and support for early-career scientists. Besides keynotes, invited and contributed talks, and poster sessions, the program will include a Career Development Workshop for trainees and junior faculty members to address career choices and milestones in a panel discussion format. It will also feature a Meet-the-Expert/Speaker Session covering a range of professional development topics, fostering an interactive platform for knowledge sharing, peer mentoring, and professional networking. Through these activities, this FASEB conference will catalyze new connections between molecular biophysics, cell and molecular biology, cancer biology, neuroscience, and drug discovery communities, enabling exchanges of cutting-edge discoveries and identification of major challenges as the field moves forward.
Grant Summary
Phase Transitions in Cellular Signaling and Disease is a NCI - National Cancer Institute grant providing up to $5K for university, nonprofit, healthcare org. Applications are due 2027-01-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $5K
2027-01-31
- 1Confirm your organization is eligible for Phase Transitions in Cellular Signaling and Disease from NCI - National Cancer Institute, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NCI - National Cancer Institute before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NCI - National Cancer Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Phase Transitions in Cellular Signaling and Disease: Frequently Asked Questions
Who is eligible for the Phase Transitions in Cellular Signaling and Disease?
Phase Transitions in Cellular Signaling and Disease is offered by NCI - National Cancer Institute and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Phase Transitions in Cellular Signaling and Disease provide?
Phase Transitions in Cellular Signaling and Disease provides up to $5K per award from NCI - National Cancer Institute. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Phase Transitions in Cellular Signaling and Disease deadline?
Applications for Phase Transitions in Cellular Signaling and Disease are due 2027-01-31 (open). Because deadlines can change, verify the date with the funder, NCI - National Cancer Institute, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Phase Transitions in Cellular Signaling and Disease?
To apply for Phase Transitions in Cellular Signaling and Disease, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NCI - National Cancer Institute.